These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15924347)

  • 1. Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy.
    Islam N; Stewart P; Larson I; Hartley P
    J Pharm Sci; 2005 Jul; 94(7):1500-11. PubMed ID: 15924347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.
    Adi H; Larson I; Chiou H; Young P; Traini D; Stewart P
    Pharm Res; 2006 Nov; 23(11):2556-65. PubMed ID: 16972185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.
    Islam N; Stewart P; Larson I; Hartley P
    J Pharm Sci; 2004 Apr; 93(4):1030-8. PubMed ID: 14999738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios.
    Adi H; Larson I; Chiou H; Young P; Traini D; Stewart P
    J Pharm Sci; 2008 Aug; 97(8):3140-52. PubMed ID: 18023007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?
    Islam N; Stewart P; Larson I; Hartley P
    Pharm Res; 2004 Mar; 21(3):492-9. PubMed ID: 15070101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Murnane D; Martin GP; Marriott C
    J Pharm Sci; 2009 Feb; 98(2):503-15. PubMed ID: 18506819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactose composite carriers for respiratory delivery.
    Young PM; Kwok P; Adi H; Chan HK; Traini D
    Pharm Res; 2009 Apr; 26(4):802-10. PubMed ID: 19015956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of adhesional properties of lactose carriers using atomic force microscopy.
    Louey MD; Mulvaney P; Stewart PJ
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):559-67. PubMed ID: 11377036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can low-dose combination products for inhalation be formulated in single crystalline particles?
    Kumon M; Kwok PC; Adi H; Heng D; Chan HK
    Eur J Pharm Sci; 2010 Apr; 40(1):16-24. PubMed ID: 20172026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.
    Handoko A; Ian L; Peter SJ
    Eur J Pharm Sci; 2009 Feb; 36(2-3):265-74. PubMed ID: 18996188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation.
    Das S; Larson I; Young P; Stewart P
    J Pharm Sci; 2009 Mar; 98(3):1015-27. PubMed ID: 18661537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scanning white-light interferometry as a novel technique to quantify the surface roughness of micron-sized particles for inhalation.
    Adi S; Adi H; Chan HK; Young PM; Traini D; Yang R; Yu A
    Langmuir; 2008 Oct; 24(19):11307-12. PubMed ID: 18759384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW; Lim LT; Heng PW
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising the surface adhesive behavior of tablet tooling components by atomic force microscopy.
    Bunker M; Zhang J; Blanchard R; Roberts CJ
    Drug Dev Ind Pharm; 2011 Aug; 37(8):875-85. PubMed ID: 21247374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate.
    Heng PW; Chan LW; Lim LT
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):393-8. PubMed ID: 10726864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a cascade impactor simulator based on adhesion force measurements to aid the development of dry powder inhalations.
    Podczeck F
    Chem Pharm Bull (Tokyo); 1997 May; 45(5):911-7. PubMed ID: 9178525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of roughness on particle adhesion in aqueous solutions: a study of Saccharomyces cerevisiae and a silica particle.
    Götzinger M; Weigl B; Peukert W; Sommer K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):44-50. PubMed ID: 17194576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.